Press release
Spinal Muscular Atrophy Market is anticipated CAGR of 14.29 percent in future
spinal-muscular-atrophy-market-countries-companies-forecast
https://www.renub.com/spinal-muscular-atrophy-market-p.php
Get Free Customization in This Report
Spinal muscular atrophy is a disease that causes muscle weakness which mostly appears in newborn children. Spinal muscular atrophy disease incidence of approximately 1 in 10,000 newborns and a prevalence of approximately 1 to 2 per 100,000 persons, globally. Spinal muscular atrophy is basically 4 types – Type 1, Type 2, Type 3 and Type 4. Most patients suffers with Spinal muscular atrophy type 1. According to Renub Research Global Spinal Muscular Atrophy (SMA) market is anticipated to grow at a CAGR of 14.29 percent in future. This double digit growth rate will happen due to expected launch of new drugs, better reimbursement options and decline in drugs prices.
Request a free sample copy of the report: https://www.renub.com/contactus.php
Spinal Muscular Atrophy (SMA) type 1 develop in less than 6 months of new born children in which patients are not in position to sit in their lifetime and normally they die within 6 months. In spinal muscular atrophy type 2, patients can sit but cannot walk. Type 2 is developed between 6-18 months of the new born children. Spinal muscular atrophy Type 3 patients can sit and walk and it developed when children age is less than 18 months. Spinal muscular atrophy Type 4 can develop during the adulthood.
Renub Research report titled “Spinal Muscular Atrophy Market Global Forecast by Countries (United States, United Kingdom, France, Germany, Spain, Italy & Japan), Drugs (Spinraza, AVXS-101, CK2127107, RG7916, Olesoxime & LMI070), Companies (Biogen Inc., Roche AG, Novartis AG, Cytokinetics Inc)” studies the global spinal muscular atrophy market and provides an all-encompassing analysis of the key growth drivers and challenges, market trends, key players and their projections for the future.
Spinal Muscular Atrophy Market New Drugs are expected to launch in recent years
At present only Biogen’s Spinraza is approved for the treatment of spinal muscular atrophy patients in the various parts of the globe such as United States, Europe, and Japan etc. Other companies are also working for new drugs development and they hope to enter in the market place very soon as their drugs are in Phase III clinical trials.
By Country - Market Segmentation
Spinal muscular atrophy market by country has been segmented into United States, United Kingdom, France, Germany, Spain, Italy and Japan. United States is a leading market place due to increasing number of treated Patients, favorable reimbursement policies and increase in healthcare expenditure.
By Total & Treated Patients - Population Segmentation
Spinal muscular atrophy Total & Treated Patients by country has been segmented into United States, United Kingdom, France, Germany, Spain, Italy and Japan. United States is dominating in the treated SMA patients globally.
By Drugs - Market Segmentation
The report by Renub Research studies the spinal muscular atrophy six drugs (Spinraza, AVXS-101, CK2127107, RG7916, Olesoxime & LMI070) details with present and estimated global sales.
The Report has been analyzed from 9 Major Viewpoints
1. Global Spinal Muscular Atrophy Market (Present & Forecast)
2. Global Spinal Muscular Atrophy Market Share, Patients Share, Treated Patients Share (Present & Forecast)
3. Country Spinal Muscular Atrophy Market (Present & Forecast)
4. Country Spinal Muscular Atrophy Patients Population (Present & Forecast)
5. Country Spinal Muscular Atrophy Treated Patients Population (Present & Forecast)
6. Spinal Muscular Atrophy Drugs Sales (Present & Forecast)
7. Global – Clinical Study on Spinal Muscular Atrophy & Drugs Pipeline
8. Growth Drivers and Challenges
9. Key Spinal Muscular Atrophy Companies Initiatives and Financial Insight
Country Covered in this Report
• United States
• United Kingdom
• France
• Germany
• Italy
• Spain
• Japan
Drugs Details Covered in this Report
• Spinraza
• AVXS-101
• CK2127107
• RG7916
• Olesoxime
• LMI070
Company Covered in this Report
• Biogen Inc.
• Roche AG
• Novartis AG
• Cytokinetics Inc
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com
Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.
225 Kristie Ln, Roswell, GA 30076, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spinal Muscular Atrophy Market is anticipated CAGR of 14.29 percent in future here
News-ID: 1343955 • Views: …
More Releases from Renub Research
United States Contact Lenses Market, Size, Share, growth ⅼ Forecast (2024 - 20 …
United States Contact Lenses Market size is predicted to be approximately US$ 4.47 Billion by 2032. The CAGR for the United States Contact Lenses market from 2024 to 2032 is 4.69%. Renub Research stated that it priced at US$ 2.96 Billion in 2023.
Thin, transparent plastic disks called contact lenses are inserted into the eye to enhance eyesight. They float on top of the cornea's protective tear film. Contact lenses,…
Indian spice Market become worth US$7.80 billion in 2023. It is expected to rise …
Indian spices have been popular worldwide considering that ancient instances because of their authentic taste and texture. They are famous for their aroma and flavor, which complements meals exceptional. Indian spice industry has played a giant position in the last seven decades. Spice growing, processing, production, grading, advertising, and other related industries have long been a key source of profits for people in India. Due to their incomparable aroma, taste,…
Global Vacuum Truck Market Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Re …
Global Vacuum Truck Market value is anticipated to be about US$ 3.11 billion by 2032. The CAGR for the industry from 2024 to 2032 is 6.53%. Renub Research said that it amounted to US$ 1.76 billion in 2023.
Vacuum trucks are innovative machines that split, accumulate, and haul away soil and different particles. Their fundamental layout consists of a truck with an extensive series tank hooked to a vacuum hose. Putting…
Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, G …
Global lung cancer diagnostics market is projected to attain about US$ 30.84 billion through 2030, as per Renub Research
Lung cancers consequences from uncontrolled cell growth, forming loads referred to as tumors. Typically originating from the lining cells of the airlines (bronchi and bronchioles), it is frequently referred to as bronchogenic cancers or carcinoma. Cigarette smoking is the primary cause, contributing to approximately 90% of instances, at the same time…
More Releases for Spinal
Spinal Non-Fusion
Spinal implants are devices used for the treatment of spinal disorders such as disproportion and instability of spine. Spine surgical devices are broadly classified into fusion and non-fusion devices. Fusion devices heals by providing immediate and rigid immobilization, and non-fusion devices treats by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating it. The advantages such as prolonged recuperation time, bone graft…
Different Approaches to Spinal Fusion Market And Control Spinal Deformity Develo …
Spinal fusion is surgery to permanently join together two or more bones in the spine so there is no movement between them. For patients who require spinal fusion surgery to treat lumbar degenerative disc disease (DDD), spinal fusion device is a treatment option.
Spinal fusion has been used for many years to treat many painful conditions in the lumbar (lower) spine. Over the past decade, there has been dramatic improvement in…
Spinal Cord Compression-Spinal Stenosis Market Progresses for Huge Profits by 20 …
The Global Spinal Cord Compression-Spinal Stenosis Market is expected to reach $ 8.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 11.5 % during 2017-2023.
Spinal stenosis is the abnormal narrowing of spinal canal causing it to restrict, which may result in a neurological deficit due to interference with neurological fibres. The associated symptoms include pain, numbness, loss of motor control etc.…
Spinal Cord Compression-Spinal Stenosis Market Report: Industry Manufacturers An …
Marketresearchfuture.com includes Global Spinal Cord Compression-Spinal Stenosis Market by indications, by diagnosis, by end users - Global Forecast till 2023 is new report.
Spinal cord compression is the second most frequent neurologic complication of cancer. Only in the United States, each year nearly 20,000 people with cancer develop spinal cord compression; this affected population represents 5% to 10% of the general cancer population.
Request Sample copy of Spinal cord compression-spinal stenosis…
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report.
As…
Spinal Implants and Spinal Devices Market Analysis, Development and Demand Forec …
The global spinal implants and spinal devices market is growing, due to increasing demand for minimally invasive surgeries, increasing number of hospitals and surgical centers, and commercial applications in areas, such as nucleus arthroplasty, stem cell technology and artificial disk replacement. The spinal fusion and fixation technology dominates the market and the non-fusion/ motion preservation technology segment is expected to grow with the fastest rate during the forecast period, due…
